title: Mucosal leishmaniasis in a Sudanese patient.
abstract: Mucosal leishmaniasis (ML) is an oral disease caused by the parasite Leishmania donovani. The disease has been proven to be pandemic in many areas of the world. It affects young men living in leishmaniasis-endemic areas. ML might be accompanied or proceeded by visceral leishmaniasis (VL), although in most of the cases seen in Sudan, ML occurs as a primary lesion. ML can mimic oral cancer or fungal infections, with ulceration as the most common finding in ML lesions. In this report, the patient came from an area known to be endemic for VL. Although the lesions were not ulcerative, the patient history was indicative for ML. Early detection and proper diagnosis were of great help in the cure and prognosis of the disease.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Department of Orthodontics, Genetics Section, University of Khartoum, Faculty of Dentistry, Khartoum, Sudan. kamalabbas@hotmail.com
authors.forename: Kamal
authors.initials: K
authors.lastname: Abbas
authors.forename: Mayson A
authors.initials: MA
authors.lastname: Musatafa
authors.forename: Shaza
authors.initials: S
authors.lastname: Abass
authors.forename: Musa M
authors.initials: MM
authors.lastname: Kheir
authors.forename: Maowia
authors.initials: M
authors.lastname: Mukhtar
authors.forename: Elwaleed M
authors.initials: EM
authors.lastname: Elamin
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Elhassan
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D009067:Mouthwashes / Q000008:administration & dosage / Q000627:therapeutic use; D013397:Sudan
chemical_list: D000981:Antiprotozoal Agents; D009067:Mouthwashes; C068538:liposomal amphotericin B; D000666:Amphotericin B; C010882:chlorhexidine gluconate; D002710:Chlorhexidine